InvestorsHub Logo

long uoip

06/27/20 12:17 PM

#80632 RE: Scruffer #80631

I wouldn't put it past the carter team to simply file 1 expert report after another that simply up the price by a fraction of a margin to further solidify the case
(affirming/validating a previous post inferring this is all a "game of winning" with lawyers)
I tried to scrutinize Teece versus Tyler's background for variables/differences but they are both WELL ESTABLISHED with various arenas of proficiency

what stood out re: Tyler's CV for PTC was ~ "competition economics" &
"the relationship between price and speed using regression analyses"
..these assertions inevitably will be the bottom line to what our PPS will be worth when all is said & done

re: previous post ~ b4 someone points out the word "biosimilar" ..feel free to amend to "similar" for our IT status infringement
re: Intellectual Property and Damages
Reasonable royalty for patent infringement involving manufacturing process and method of treatment for a biosimilar product